Board Certified Neurologist and Clinical Pharmacologist, obtained PhD in Alzheimer's research in 1980. Head of Neurology department in University Hospital in Zagreb Croatia from 1999-2005. From 2005 till 2013 Senior Medical Director at i3 (Inventiv). From 2013 Vice President of Neuroscience in Worldwide Clinical Trials. Author over 100 peer reviewed articles in drug development for neurodegenerative disorders.

- Bachelor's degree in Health Sciences and Technology at ETH Zurich - Master's degree in Health Sciences and Technology at ETH with a major in neuroscience - PhD Student at ETH Zurich/University of Zurich, focus on multimodal imaging

Torbjörn Bäckström MD., PhD. senior professor at department of clinical sciences, Umea University, Umea Sweden. Professor Bäckström’s research focus has been neurosteroids effects and mechanisms in the brain. The GABA-system, and disorders and symptoms caused by neuroactive steroids via the GABA-A system. He has published more than 400 scientific publications and he is frequently invited key-note speaker on scientific meetings around the world. Professor Bäckström has founded three pharmaceutical companies developing medication based on the results from Professor Bäckström’s research. One of the companies Umecrine Cognition AB is involved in developing drugs against memory and learning deteriorations.

PhD Research Scholar Kajal Email: kajalbagri1796@gmail.com Mobile: +919466153574 Objective: I wish to append myself with the works of an esteemed lab and transfuse all my cumulus talents, knowledge and hard work into a challenging and creative environment that encourages continuous learning and provides exposure to new ideas and stimulates personal and professional growth. Personal Dossier Kajal Date of Birth : July 01, 1996 Nationality : Indian Email : kajalbagri1796@gmail.com Contact No. : +91-9466153574 Current Position : M Pharm. Research Scholar Field of Specialization : Pharmacology Address : H.No. 874-D, street no 4, phase II, Laxman Vihar, Gurugram, 122001 Qualification Details Sr. Description Board/University Year Percentage/ CGP 1. M-Pharm (Pharmacology) Maharaja Ranjit Singh Punjab Technical University, Bathinda. 2018-20 8.61 2. B. Pharm Bhagat Phool Singh Mahila Vishwavidyalaya, Khanpur Kalan (Sonipat) 2014-18 74.5% 3. H.S.C Jiwan Jyoti Sr, Sec. Public School affiliated with HBSE 2014 86.4% 4 S.S.C Jiwan Jyoti Sr, Sec. Public School affiliated with HBSE 2012 91.8%  Qualified GPAT 2019 with All India Rank 8524.  Secured 3rd position in oral presentation in International conference in collaboration with APTI- Punjab & Constituent colleges of Adesh University on 16th January, 2020 on “Embelin restores striatal neurochemistry and attenuates MPTP-induced motor deficit in rats”. Working Experience  One month industrial training in Dagon pharmaceutical pvt Ltd Baddi, Solan, H.P.  One month hospital training at Civil Hospital, Gurgaon.  Two years experience in animal handling, oral dosing. i.p. injections etc.  Experience in biochemical estimation, neurotransmitters level using HPLC  xperience in research writing. Additional Qualifications Research & Academic Distinctions (Overview) Core competencies  Ability to rapidly build relationship and setup trust.  Confident and Determine  Ability to cope up with different situations.  Excellent interpersonal skills to relate with every kind of personality.  Self-motivated, enthusiastic with ability to give results individually or with team Academic Distinctions : Conferences attended (National / International) 5 Memberships 1 Award 1 Research Project Worked on “Neuroprotective Potential of Vinpocetine against weight drop induced Traumatic Brain Injury in rats” under the kind supervision of Dr. Rahul Deshmukh at Department of Pharmaceutical Sciences, Maharaja Ranjit Singh Punjab Technical University Bathinda. Book Chapter Kajal Bagri, Vivek Sharma, Rahul Deshmukh* “COMPREHENDING TYPE-I DIABETES MELLITUS” In: Diabetes and Diabetic Complications, ISBN: 978-1-53619-177-6, 2021 Nova Science Publishers, Inc. 1-20. Publication Kajal Bagri, Puneet Kumar, Rahul Deshmukh* Neurobiology of Traumatic Brain Injury” Taylor & Francis, 2021. National and International conferences attended Kajal, Rahul Deshmukh. “Neuroprotective role of vinpocetine against weight drop induced Traumatic brain injury in rats” Presented Poster in IBRO/APRC Nepal School on Understanding of Neuroscience and Spectrum of Neurogenetic Disorders from 20th-25th August 2021. Kajal, Rajat, Rahul Deshmukh “Embelin restores striatal neurochemistry and attenuates MPTP- induced motor deficit in rats” Presented oral presentation in International conference in collaboration with APTI- Punjab & Constituent colleges of Adesh University on 16th January. Kajal, Shivreet Kaur, Rahul Deshmukh. “Therapeutic role of vinpocetine in epilepsy induced co- morbid depression and cognitive dysfunction in ptz kindled rats.” Presented Poster in 4th IBRO- APRC Chandigarh associate school on translational neuroscience from 10th -17th November 2019, organised by UIPS, PU, Chandigarh. , 2020. Kajal, Rahul Deshmukh. “Epigenetics in Alzheimer’s disease ” presented poster in 2nd north zone conference by Indian Pharmacological Society at Maharishi Markandeshwar University, Mullana, Punjab, from 15th-16th Feb, 2019. Kajal, Priyanka, Rahul Deshmukh* “Neuroprotective Potential of Fingolimod in Experimental Sporadic Dementia in Rats”. Presented E-poster at 24th National Annual Convention of Associaton of Pharmaceutical Teachers of India, APTICON-2019, Holistic Contribution of Pharmacy Gurus for Future Global Leaders- Vision 2047, hosted by DIT University, Dehradun, Uttarakhand, INDIA from 11-13th October,2019. Extra-Curricular Activities  Participate in quiz competitions at school level and college level.  Won prize in Rangoli, essay writing at school level and college level. Computer knowledge: Proficiency in Internet surfing, MS-Office, Graph pad Prism, Mendeley, HPLC and other softwares useful in the field of pharmacy. Memberships of Societies Registered Pharmacist from Haryana State Pharmacy Council, Panchkula. Declaration

Fangfang Bai is a Senior Scientist in the department of Data & Genome Science at Merck Research Laboratory Cambridge. She joined Merck since December 2019. She is leading the efforts on utilizing CRISPR screening and iPSC-derived human microglial-like cells to identify new therapeutic targets for neurodegenerative diseases. She has established the CRISPR screening platform and studied the functional consequences of genetic perturbations in iPSC-derived human microglial-like cells. Fangfang earned her PhD at Ocean University of China. She did her postdoc training at Department of Microbiology and Immunology, University of Miami Miller School of Medicine and Department of Molecule Biology and Microbiology, Tufts University School of Medicine. During her postdoc works, she was mainly focusing on the IFN responses in innate immune system.

Kieran is a PhD Statistics student at King's College London, supervised by Professor Steven Gilmour. His research is around the applications and development of statistical methodology across different types of data to improve our understanding of Parkinson's Disease. In particular, his interests are in applied/medical statistics, signal processing/time series analysis, experimental design, machine learning and video & image processing and analysis.

I am a PhD student at Alzheimer Center Amsterdam on the POLAR project: Psychosocial effects of COVID-19 in Alzheimer's disease. In addition, I work as a neuropsychologist at the memory clinic of Alzheimer Center Amsterdam.

I am a second year PhD candidate at the Department of Clinical Sciences, Lund University. My area of research is focused on blood p-tau as a diagnostic and prognostic biomarker of Alzheimer´s disease.

Dr. Sri Banerjee has nearly 20 years of experience in the areas of Public Health and Global Health. He has worked at the Centers for Disease Control in the area of infectious diseases and has worked on public health projects worldwide. Additionally, he has conducted award-winning research in the areas of HIV and chronic diseases and has experience writing grant proposals. He has conducted geospatial analysis to determine the presence of food deserts. His experience as a public health consultant and serving on the board of directors of public health organizations help in providing a practical front line perspective to the learning of public health. Also, he has experience in advising students about public health projects. He has also coauthored and published more than 50 research articles in prestigious journals such as the Lancet, and the Journal of American Medical Association with emphasis on global health, social epidemiology, cancer, and injury prevention. More recently, his research has received widespread attention from prominent media outlets such as Yahoo News, Healthline, HealthDigest, and MSN Health News. He uses his medical clinical expertise and his research acumen to guide his students.

Miquel Aguilar Barbera. Born in Sabadell (Spain) (1950). I work in Àptima Mutua Terrassa (2000-2022), and in Neurology & Neuropsychology Institute of Sabadell (1980-2022). Head of the Neurology Service of Mutua Terrassa Hospital (1990-2017). Master in Hospital Management and Associate Professor at the Faculty of Medicine (University of Barcelona) (1995-2017). President of the Catalan Society of Neurology (SCN) (1986-1988), secretary of the Study Group of Cognition and Behavior (SCN) (2018-2020). Vice-president of “Convives con la Espasticidad" (2014-2020) Founding member of AVAN (1993) (Patients and Families Association). Medical Director (1993-2001). President (2001-2011). Editor of the magazine "Endavan't" (1995-2011). Honorary Member (2018-2022). Founding member, Medical Director, and President of the PARKINSON-ARA Association (2012-2022). Founding member and Coordinator of ADRIS (Alzheimer Disease Research International Society) (2018 -2022) Coordinator of the Clinical Practice Guide in Dementia of the Ministry of Health and Social Affairs of Spain (2011); and Reviewer of the National Guide for Dementias (2019-2022). Coordinator of the Dementia Plan of Catalonia (2011) and collaborator in the new Dementia Plan (Plademcat) (2022-2025). Team member of COPPADIS-2015 (National Parkinson's Disease Study) (2015-2022) Local social awards in Terrassa (2003) and Sabadell (2005) My Neurological interest: Dementia. Movements disorders. Functional neurological disease. Headache, and Caregiver’s burden.

I am currently an Associate Research Scientist in the Department of Neurology at Columbia University, New York. I am funded by an Early Career Investigator Innovation Award from the William N. and Bernice E. Bumpus Foundation. The focus of my research encompasses two overarching research questions: 1) Why and how do dopaminergic neurons selectively degenerate in Parkinson’s disease (PD)? and 2) What is the function of the alpha-synuclein protein, in which location, and how does too much endogenous alpha-synuclein contribute to PD? To begin to answer these research questions I use patient-derived induced pluripotent stem cell (iPSC) lines carrying pathogenic mutations in the alpha-synuclein gene SNCA. I directly differentiate these iPSC lines carrying endogenous levels of physiological alpha-synuclein into midbrain dopaminergic neurons and identify screenable functional phenotypes against healthy controls and/or Cripsr-Cas9 gene-edited isogenic controls. My current work is investigating the function of alpha-synuclein at the mitochondrial associated ER membranes (MAMs). These MAMs are transient, functional domains that regulate lipid homeostasis, and I pose that alpha-synuclein mediated modulation of MAM domains and regulation of lipid dyshomeostasis may contribute to PD neurodegeneration, and that the mechanism of cell death may be non-cell autonomous.